Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/21/10 → 12/31/13 |
Funding
- PPD Development (C18770/2043 // C18770/2043)
- Cephalon, Inc. (C18770/2043 // C18770/2043)
PROT# C18770/2043: An Open-Label Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy
- Singhal, Seema (PD/PI)
Project: Research project